You are here: Industry Insights > Aptamer Group

News List

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer enabled therapeutics firstwordpharma
July 23, 2021
Aptamer Group, the developer of Optimer™ therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, today announce a research collaboration to identify new Optimer™-enabled therapeutics.
Aptamer Group: UK Biotech Business Raises $2.2M Investment b3cnewswire
July 24, 2018
Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme.
Aptamer Group: UK Biotech Business Raises $2.2M Investment b3cnewswire
July 04, 2018
Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme.